VIGH Director, Sten Vermund, M.D., Ph.D. will participate in a satellite session entitled, Health Disparities, Hurdles and Hope: Ending the HIV Epidemic in the U.S. on Sunday, July 22, and moderate a panel discussion entitled, Treatment as Prevention: From Science to Implementation on Tuesday, July 24. Presentions by Vanderbilt investigators total 27 and 17 of those are from VIGH core and affiliated faculty. Six abstracts from the AIDS International Research Training Program (AITRP) alumni include four posters and two oral poster discussions by Vikrant Sahasrabuddhe, M.D., M.P.H., Dr.PH  (AITRP Alum 2006) and Han-Zhu Qian, M.D., Ph.D. (AITRP Alum 2005).

Core Faculty

LBPE49 - Poster Exhibition
Traditional healer consultation is associated with a 3 month delay in HIV testing among symptomatic HIV-positive patients in rural Mozambique
C. Audet1, M. Blevins2, C. Rosenberg3, S. Farnsworth3, J. Fernandez4, J. Salato4, T. Moon4,5, S. Vermund4,6
1Vanderbilt University, Institute for Global Health, Preventive Medicine, Nashville, United States, 2Vanderbilt University, Institute for Global Health, Biostatistics, Nashville, United States, 3Peace Corps Volunteer Mozambique, Quelimane, Mozambique, 4Friends in Global Health, Quelimane, Mozambique, 5Vanderbilt University, Institute for Global Health, Pediatrics, Nashville, United States, 6Vanderbilt University, Institute for Global Health, Preventive Medicine, Pediatrics, Infectious Disease, Nashville, United States

MOPE114 - Poster Exhibition
Relation between referral site and adult mortality in the 24 months post ART initiation in rural Zambézia, Mozambique
M. Blevins1,2, D.D. Parrish1,3,4, L.M. Vaz1,4,5, T.D. Moon1,4,6, E. José4, F.G. Ferreira4, S.H. Vermund1, B.E. Shepherd2
1Vanderbilt Institute for Global Health, Nashville, United States, 2Vanderbilt University School of Medicine, Biostatistics, Nashville, United States, 3Vanderbilt University School of Medicine, Medicine, Nashville, United States, 4Friends in Global Health, Maputo, Mozambique, 5Vanderbilt University School of Medicine, Preventive Medicine, Nashville, United States, 6Vanderbilt University School of Medicine, Pediatrics, Nashville, United States

MOPE068 - Poster Exhibition
Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for quality improvement and continuing program/community development in PEPFAR
S.H. Vermund1, M. Blevins1,2, L.M. Vaz1,3,4, B.E. Shepherd2, D.D. Parrish1,5, L. Moiane4, F.G. Ferreira4, K. Faque6, T.D. Moon1,4,7
1
Vanderbilt Institute for Global Health, Nashville, United States, 2Vanderbilt University School of Medicine, Biostatistics, Nashville, United States, 3Vanderbilt University School of Medicine, Preventive Medicine, Nashville, United States, 4Friends in Global Health, Maputo, Mozambique, 5Vanderbilt University School of Medicine, Medicine, Nashville, United States, 6Provincial Health Directorate, Zambézia, Mozambique, 7Vanderbilt University School of Medicine, Pediatrics, Nashville, United States

MOPE117 - Poster Exhibition
Predictors of adult mortality and loss-to-follow-up within two years of initiation of combination antiretroviral therapy in rural Mozambique
T.D. Moon1,2,3, L.M. Vaz1,3,4, D.D. Parrish1,5, E. Valverde3, A. Baptista6, M. Blevins1,7, F.G. Ferreira3, B.E. Shepherd7, S.H. Vermund1
1
Vanderbilt Institute for Global Health, Nashville, United States, 2Vanderbilt University School of Medicine, Pediatrics, Nashville, United States, 3Friends in Global Health, Maputo, Mozambique, 4Vanderbilt University School of Medicine, Preventive Medicine, Nashville, United States, 5Vanderbilt University School of Medicine, Medicine, Nashville, United States, 6Provincial Health Directorate, Zambézia, Mozambique, 7Vanderbilt University School of Medicine, Biostatistics, Nashville, United States

MOPE118 - Poster Exhibition
Timely initiation of antiretroviral therapy is distinct by clinic and over time in rural Mozambique
L.M. Vaz1,2,3, M. Blevins1,4, A. Baptista5, M. Sidat6, D.D. Parrish1,7, W. Silva3, S.H. Vermund1, T.D. Moon1,3,8
1
Vanderbilt Institute for Global Health, Nashville, United States, 2Vanderbilt University School of Medicine, Preventive Medicine, Nashville, United States, 3Friends in Global Health, Maputo, Mozambique, 4Vanderbilt University School of Medicine, Biostatistics, Nashville, United States, 5Provincial Health Directorate, Zambézia, Mozambique, 6Universidade Eduardo Mondlane, Maputo, Mozambique, 7Vanderbilt University School of Medicine, Medicine, Nashville, United States, 8Vanderbilt University School of Medicine, Pediatrics, Nashville, United States

MOPE695 - Poster Exhibition
Overcoming barriers to health care access for single mothers in coastal Kenya
J.J. Cohen1, M. Blevins2,3, A. Mapenzi4, L. Reppart4, J. Reppart4, R. Mainthia1, C.W. Wester2,5,6
1
Vanderbilt University School of Medicine, Nashville, United States, 2Vanderbilt University Institute for Global Health, Nashville, United States, 3Vanderbilt University School of Medicine, Biostatistics, Nashville, United States, 4Caris Foundation International, Kenya, Malindi, Kenya, 5Vanderbilt University School of Medicine, Infectious Diseases, Nashville, United States, 6Harvard School of Public Health, Immunology & Infectious Diseases, Boston, United States

THPDC0102 - Oral Poster Discussion
Modeling of HIV epidemic among men who have sex with men in Beijing, China
Presented by Han-Zhu Qian (United States) H.-Z. Qian1, J. Lou2, Y. Ruan3, G.F. Webb4, Y. Shao3, S. Vermund1
1
Vanderbilt Institute for Global Health, Nashville, United States, 2Shanghai University, Department of Mathematics, Shanghai, China, 3National Center for AIDS/STD Control and Prevention, China CDC, Division of Virology and Immunology, Beijing, China, 4Vanderbilt University, Department of Mathematics, Nashville, United States

THPE527 - Poster Exhibition
Social drivers of the HIV epidemic in Pakistan
A. Altaf1,2
1
Bridge Consultants Foundation, Karachi, Pakistan, 2Vanderbilt University, Vanderbilt Institute for Global Health, Nashville, United States

THPE538 - Poster Exhibition
Gender differences in timely initiation of highly active antiretroviral therapy (HAART) in north central Nigeria
D. Parrish1, M. Aliyu1, K. Megazzini2, M. Blevins1, U. Gebi3, M. Muhammad3, M.L. Ahmed4, O. Nwanyanwu4, B. Shepherd1, S. Vermund1, C.W. Wester1
1
Vanderbilt Institute for Global Health, Nashville, United States, 2Westat, Rockville, United States, 3Friends in Global Health, Abuja, Nigeria, 4Centers for Disease Control and Prevention (CDC), Abuja, Nigeria

THPE544 - Poster Exhibition
Retention in HIV care and treatment among women referred from prevention of mother-to-child transmission programs in rural Mozambique
D.D. Parrish1,2, M. Blevins1,3, T.D. Moon1,4,5, L.M. Vaz1,5,6, F.G. Ferreira5, E. José5, B.E. Shepherd3, M. Sidat7, S.H. Vermund1
1
Vanderbilt Institute for Global Health, Nashville, United States, 2Vanderbilt University School of Medicine, Medicine, Nashville, United States, 3Vanderbilt University School of Medicine, Biostatistics, Nashville, United States, 4Vanderbilt University School of Medicine, Pediatrics, Nashville, United States, 5Friends in Global Health, Maputo, Mozambique, 6Vanderbilt University School of Medicine, Preventive Medicine, Nashville, United States, 7Universidade Eduardo Mondlane, Maputo, Mozambique

TUPE288 - Poster Exhibition
Predictors of HIV testing awareness and service uptake among women in rural Mozambique: results from a province-wide survey
H. Paulin1, A. Vergara2, M. Blevins2,3, N. Hinton2, J. Koethe1, S. Vermund2, C.W. Wester1,2,4, L. Vaz2,5
1
Vanderbilt University School of Medicine, Department of Medicine, Division of Infectious Diseases, Nashville, United States, 2Vanderbilt University, Vanderbilt Institute for Global Health, Nashville, United States, 3Vanderbilt University, Department of Biostatistics, Nashville, United States, 4Harvard School of Public Health, Department of Immunology & Infectious Diseases, Boston, United States, 5Friends in Global Health, Maputo, Mozambique

WEPDC0205 - Oral Poster Discussion
Effectiveness of behavioral interventions on unprotected sex among people living with HIV: a system review and meta-analysis
Presented by Lu Yin (United States) L. Yin1, N. Wang2, Y. Ruan2, Y. Shao2, S. Vermund1, H.-Z. Qian1
1Vanderbilt Institute for Global Health, Nashville, United States, 2National Center for AIDS/STD Control and Prevention, China CDC, Division of Virology and Immunology, Beijing, China

WEPE590 - Poster Exhibition
What can one garden do? Addressing nutrition needs, adherence levels and empowering communities in Nyanza, Kenya
N. Derman1,2, DIG Program Staff, Lwala Community Alliance Staff, VGH
1Development in Gardening (DIG), Denver, United States, 2Vanderbilt Institute for Global Health, Nashville, United States

VIGH Affiliated Faculty

LBPE29 - Poster Exhibition
Trends in antiretroviral therapy initiation and virologic suppression among newly clinically-eligible HIV-infected individuals in North America, 2001 to 2009
D.B. Hanna1, K. Buchacz2, K.A. Gebo1, N.A. Hessol3, M.A. Horberg4, L.P. Jacobson1, G.D. Kirk1, M.M. Kitahata5, P.T. Korthius6, R.D. Moore1, S. Napravnik7, P. Patel2, M.J. Silverberg8, T.R. Sterling9, J.H. Willig10, B. Lau1, K.N. Althoff1, A.D. Collier5, M.E. Ohl11, J.E. Thorne1, M.J. Gill12, M.B. Klein13, J.N. Martin3, B. Rodriguez14, S.B. Rourke15, S.J. Gange1, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the IeDEA
1Johns Hopkins University, Baltimore, United States, 2Centers for Disease Control and Prevention (CDC), Atlanta, United States, 3University of California, San Francisco, San Francisco, United States, 4Kaiser Permanente, Rockville, United States, 5University of Washington, Seattle, United States, 6Oregon Health and Science University, Portland, United States, 7University of North Carolina at Chapel Hill, Chapel Hill, United States, 8Kaiser Permanente, Oakland, United States, 9Vanderbilt University, Nashville, United States, 10University of Alabama at Birmingham, Birmingham, United States, 11Iowa City VA Medical Center, Iowa City, United States, 12University of Calgary, Calgary, Canada, 13McGill University, Montreal, Canada, 14Case Western Research University, Cleveland, United States, 15University of Toronto, Toronto, Canada

MOAB0302 - Oral Abstract
Tolerability among HIV-positive persons of three months of once-weekly rifapentine + INH (3HP) versus 9 months of daily INH (9H) for treatment of latent tuberculosis infection: the PREVENT TB Study (TBTC Study 26/ACTG 5259)
Presented by Timothy Sterling (United States) T. Sterling1, C. Benson2, N. Shang3, J. Miro4, B. Grinsztejn5, R. Chaisson6, A. Lucchetti7, J. Sanchez8, N. Scott3, E. Villarino3, AIDS Clinical Trials Group, Tuberculosis Trials Consortium
1Vanderbilt University, Nashville, United States, 2University of California - San Diego (UCSD), San Diego, United States, 3Centers for Disease Control & Prevention, Atlanta, United States, 4Agencia de Salut Publica, Barcelona, Spain, 5Fundação Oswaldo Cruz, IPEC Evandro Chagas, Rio de Janeiro, Brazil, 6Johns Hopkins University, Baltimore, United States, 7Inmensa, Lima, Peru, 8Impacta, Lima, Peru

MOPDC0302 - Oral Poster Discussion
Trends in antiretroviral therapy use, HIV RNA plasma viral load and CD4 T-lymphocyte counts at death among HIV-positive persons in care in the United States, 2000-2008
Presented by Keri N Althoff (United States). K.N. Althoff1, K. Buchacz2, I. Hall2, J. Zhang1, D.B. Hanna1, P. Rebeiro1, S.J. Gange1, R.D. Moore1, M. Kitahata3, K.A. Gebo1, J. Martin4, A.C. Justice5, M. Horberg6, R.S. Hogg7, T.R. Sterling8, A. Cescon7, M.B. Klein9, J. Thorne1, H. Crane3, M.J. Mugavero10, S. Napravnik11, G.D. Kirk1, L.P. Jacobson1, B. Rodriguez12, J.T. Brooks2, North American AIDS Cohort Collaboration on Research and Design
1Johns Hopkins University, Baltimore, United States, 2Centers for Disease Control and Prevention (CDC), Atlanta, United States, 3University of Washington, Seattle, United States, 4University of California at San Francisco, San Francisco, United States, 5Yale University and the VA Connecticut Healthcare System, New Haven, United States, 6Mid-Atlantic Permanente Research Institute, Rockville, United States, 7BC Centre for Excellence in HIV/AIDS and Simon Fraser University, Vancouver, Canada, 8Vanderbilt University, Nashville, United States, 9McGill University, Montréal, Canada, 10University of Alabama, Birmingham, United States, 11University of North Carolina, Chapel Hill, United States, 12Case Western Reserve University, Cleveland, United States

MOPE089 - Poster Exhibition
Prevalence and factors associated with renal dysfunction in HIV positive and negative adults at the University Teaching Hospital, in Lusaka
J. Banda1, A. Mweemba2, S. Siziya3, M. Mweene2, B. Andrews4, S. Lakhi2
1School of Medicine, University of Zambia, Medicine, Lusaka, Zambia, 2University Teaching Hospital, Medicine, Lusaka, Zambia, 3Department of Public Health, University of Zambia, Public Health, Lusaka, Zambia, 4Vanderbilt University, Medicine, Nashville, United States

MOPE094 - Poster Exhibition
Tenofovir-associated kidney function decline with a PI-based versus NNRTI-based regimen
A. Abraham1, B. Lau1, M. Estrella2, L. Szczech3, T. Sterling4, S. Rourke5, B. Rodriguez6, A. Rachlis5, C. Parikh7,8, S. Napravnik9, R. Moore2, D. Moore10,11, J. Martin12, M. Klein13, M. Kitahata14, G. Kirk1, Y. Jing1, M. Horberg15, M. Harris16,17, M.J. Gill18, K. Gebo2, J. Eron9, H. Crane14, R. Bosch19, C. Benson19, K. Anastos20, K. Altoff1, G. Lucas2, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
1Johns Hopkins Bloomberg School of Public Health, Epidemiology, Baltimore, United States, 2Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, United States, 3Duke University Medical Center, Department of Medicine, Durham, United States, 4Vanderbilt University Medical Center, Nashville, United States, 5University of Toronto, Toronto, Canada, 6Case Western Reserve University, Cleveland, United States, 7Yale School of Medicine., New Haven, United States, 8Veterans Affairs Medical Center, Clinical Epidemiology Research Center, West Haven, United States, 9University of North Carolina, Chapel Hill, United States, 10British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 11University of British Columbia, Faculty of Medicine, Vancouver, Canada, 12University of California - San Francisco, San Francisco, United States, 13McGill University, Montreal, Canada, 14University of Washington at Harborview Medical Center, Seattle, United States, 15Kaiser Permanente Northern California, Oakland, United States, 16University of British Columbia, Vancouver, Canada, 17St Paul's Hospital - AIDS Research Program, Vancouver, Canada, 18University of Calgary, Calgary, Canada, 19Harvard School of Public Health, Boston, United States, 20Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, United States